Could this technology effectively deliver vaccines through oral ingestion?

Researchers at Cambridge University have been working to develop a vaccine that can be universal - taken any time or any place - no matter the supply chain. They've been working on a vaccine that can survive the trip through the digestive system and make it to the small intestine where it can properly break down to deliver the active microbes to the immune system. The ultimate goal with this technology is to develop something that's needle free that can be a especially effective in developing countries. According to Bioscience Technology, as the technology goes into Phase I testing, they are looking to develop a dual vaccine for dtyphoid and enterotoxigenic Escherichia coli (ETEC).

Find out more about the technology here:

Vaccine development and production will be a main focus this year at BioProcess International. Novartis Vaccines & Diagnostics will join us to present Preparation of Highly Concentrated Influenza Vaccine for Use in Novel Delivery Approaches and Formulation of the Next Generation of Vaccine Adjuvants and Delivery Systems looking at new, innovative delivery systems that can better ensure safety and deliverability from production to the patient. For more information about these sessions and the rest of the program, download the agenda. If you'd like to join us in Boston September 16-19, as a reader of this blog when you register to join us and mention code BLOG13JP, you'll save 20% off the standard rate.